Oncology & Cancer

Certain factors linked with discontinuing breast cancer therapy

For women with hormone receptor-positive breast cancer, long-term endocrine therapy can greatly reduce the risk of recurrence. Many women, especially those in underserved populations, do not continue treatment, however. A ...

Oncology & Cancer

Endocrine therapy lowers QOL for breast cancer patients

(HealthDay)—Endocrine therapy reduces the quality of life of breast cancer patients, especially for postmenopausal women, according to a study recently published in the Annals of Oncology.

Oncology & Cancer

Breast cancer recurrence risk lingers years after treatment ends

Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators ...

page 1 from 4